- Veritas Pharma is unlocking the science underlying medical cannabis
- Clinically profiling select cannabis strains – pharmacologically identifying strains for specific disease conditions
- Entering human clinical studies with valuable IP’s in place
There is growing support for medicinal cannabis. Repeated peer-reviewed studies have demonstrated positive patient responses in a variety of maladies. However, to date, the response has been largely anecdotal, and, unlike rigorous pharmacology, the precise mechanisms and chemical profiles of cannabinoids remain unknown. Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.
Led by experienced management and bolstered with veteran academic pharmacologists, anesthetists and chemists, Veritas Pharma is rapidly unlocking the science underlying medical cannabis. The company chemically profiles different marijuana cultivars (specific plant varieties produced in cultivation by selective breeding). The cultivars are then pharmacologically profiled to identify disease-specific strains, and once these stringent protocols are achieved, Veritas performs clinical trials to establish…
More from CannabisNewsWire
- Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency
- Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals
- ChineseInvestors.com, Inc. (CIIX) Partners with Global E-commerce Behemoths
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
